Form 4 for LEXX Lexaria Bioscience Corp.
Accepted 2024-08-13 00:00:00 ET · period of report 2024-08-12 · accession 0001855763-24-000013 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-08-13 | 2024-08-12 | LEXX | TURKEL CATHERINE C. | Dir | P - Purchase | $3.13 | +1,600 | 3,100 | +107% | +$5,008 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | common shares | 2024-08-12 | P | A | 1,600 | $3.13 | 3,100 | D | — | — |